乔治临床( George Clinical ) Awarded Taiwanese Drug License

乔治临床( George Clinical ) Awarded Taiwanese Drug License

 SYDNEY, May 15, 2019 – 乔治临床( George Clinical ), a global scientifically-backed clinical research organization (CRO), has significantly expanded its capabilities in Taiwan having been granted a license to import drugs into the country for clinical trials on behalf of sponsors.  The development will be particularly helpful for small to mid-sized clinical trial clients who […]

了解更多

2019年5月14日
[addtoany buttons='facebook,twitter,linkedin']

EPS International and 乔治临床( George Clinical ) Form Strategic Partnership for the Asia-Pacific Region

Sydney, Australia, April 24, 2019 – EPS International Holdings Co., Ltd. (HQ: Tokyo, Japan; Representative Director and President: Hisashi Tanaka; “EPSI” hereafter) and 乔治临床( George Clinical ) Pty Ltd (HQ: Sydney, Australia; Executive Chairman: Glenn Kerkhof; “乔治临床( George Clinical )” hereafter) announced today that they have reached an agreement on a strategic partnership that will enhance […]

了解更多

2019年4月24日
[addtoany buttons='facebook,twitter,linkedin']

乔治临床( George Clinical ) Client Noxopharm Announces Chemotherapy Enhancement Program Expansion

Noxopharm, a clinical-stage Australian drug development company currently working with 乔治临床( George Clinical ), is seeking to establish Veyonda®, an innovative dosage formulation of the experimental anti-cancer drug idronoxil, as “an essential adjunct to all forms of radiotherapy in the treatment of prostate cancer, both late-stage and early-stage prostate cancer,” according to an announcement last […]

了解更多

2019年4月20日
[addtoany buttons='facebook,twitter,linkedin']

乔治临床( George Clinical ) Scientific Leader Named Chief Medical Officer of OneOncology

OneOncology, a national partnership of community oncologists, recently announced that Lee Schwartzberg, MD, FACP, a member of the 乔治临床( George Clinical ) scientific leadership committee, has been named Chief Medical Officer (CMO). According to OneOncology, the CMO position “provides a dynamic link between OneOncology and its physician partners, demonstrating the shared, foundational commitment to a physician-driven, […]

了解更多

2019年4月17日
[addtoany buttons='facebook,twitter,linkedin']

Late Breaking Clinical Trial CREDENCE Webcast to Stream this Month

ISN World Congress of Nephrology will be live streaming “Late Breaking Clinical Trials” from WCN 2019. The purpose of the webcast is to give the worldwide nephrology community in-depth understanding of three major nephrology studies, including the CREDENCE study for which 乔治临床( George Clinical ) plays a critical role.   The session will be streamed […]

了解更多

2019年4月5日
[addtoany buttons='facebook,twitter,linkedin']

乔治临床( George Clinical ) Strengthens Asia-Pacific Presence with New Singapore Location

乔治临床( George Clinical ), a global scientifically backed clinical research organization, (CRO) has expanded its footprint in Asia with the addition of a new presence in Singapore. The new office and entity in Singapore, which was established in July, were requisites for 乔治临床( George Clinical ) to act as a local clinical trial sponsor for […]

了解更多

2019年4月2日
[addtoany buttons='facebook,twitter,linkedin']

乔治临床( George Clinical ) Promotes Maria Ali to the Role of Chief Medical Officer

OVERLAND PARK, KS, March 6, 2019 乔治临床( George Clinical ), a leading Asia-Pacific based clinical research organization (CRO) with global capabilities, today announced that Dr. Maria Ali has been promoted to Chief Medical Officer to be based out of Raleigh, North Carolina. This move further solidifies the strategic growth of 乔治临床( George Clinical ) throughout […]

了解更多

2019年3月6日
[addtoany buttons='facebook,twitter,linkedin']

乔治临床( George Clinical ) Congratulates Parent Company The George Institute For Global Health For Securing $12 Million To Tackle Worlds Biggest Killers

[Sydney, Australia] 乔治临床( George Clinical ) congratulates its parent company, The George Institute for Global Health for securing $12 million from the National Health and Medical Research Council (NHMRC), Australia’s peak funding body for medical research. These grants will support The Institute’s scientific leaders to improve the lives of people living with chronic kidney disease, […]

了解更多

2019年2月12日
[addtoany buttons='facebook,twitter,linkedin']

乔治临床( George Clinical )’s Parent Company The George Institute For Global Health Secures Largest Ever NHMRC Project Grant To Benefit People With Kidney Disease

乔治临床( George Clinical ) congratulates its parent company, The George Institute for Global Health for securing a project grant that could transform the treatment of chronic kidney disease (CKD) globally and benefit millions of people globally. The $5.5 million awarded by the National Health and Medical Research Council (NHMRC), Australia’s peak funding body for medical […]

了解更多

2019年2月5日
[addtoany buttons='facebook,twitter,linkedin']

乔治临床( George Clinical ) Scientific Leader research contributions recognized with leading Lancet profile.

乔治临床( George Clinical ) welcomes the recognition of Professor Craig Anderson as profiled in the premier medical journal The Lancet which identified him as “a front runner in stroke research”. “It is our engagement with scientific leaders, such as Professor Anderson, that sets 乔治临床( George Clinical ) apart from other CROs,” said Philip Gregory, Managing […]

了解更多

2019年1月29日
[addtoany buttons='facebook,twitter,linkedin']

Join Our Mailing List

required
required
required
required
I wish to subscribe to George Clinical communications.
required

在您的网络中添加 乔治临床( George Clinical )